{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:01:35Z","timestamp":1790726495613,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":236,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02740","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:06:37Z","timestamp":1787727997000},"page":"e02740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Successful treatment of severe influenza-associated pulmonary aspergillosis with invasive tracheobronchitis and bronchial asthma using combination antifungals and omalizumab: A case report"],"prefix":"10.1016","volume":"45","author":[{"given":"Wei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmeng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.idcr.2026.e02740_bib1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.idcr.2026.e02740_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02740_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chest.2023.09.019","article-title":"Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis","volume":"165","author":"Lu","year":"2024","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02740_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02740_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","article-title":"Invasive tracheobronchial aspergillosis in critically Ill patients with severe Influenza. A clinical trial","volume":"202","author":"Nyga","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02740_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/jof9030312","article-title":"Managing the next wave of influenza and\/or SARS-CoV-2 in the ICU\u2014practical recommendations from an expert group for CAPA\/IAPA patients","volume":"9","author":"Peral","year":"2023","journal-title":"J Fungi"},{"issue":"166","key":"10.1016\/j.idcr.2026.e02740_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0114-2022","article-title":"Pulmonary aspergillosis: diagnosis and treatment","volume":"31","author":"Lamoth","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.idcr.2026.e02740_bib8","unstructured":"From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2026. Available from: https:\/\/ginasthma.org\/wp-content\/uploads\/2026\/05\/GINA-2026-Strategy-Report-WMS.pdf."},{"issue":"1","key":"10.1016\/j.idcr.2026.e02740_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1164\/rccm.202410-2045ST","article-title":"Treatment of invasive pulmonary aspergillosis and preventive and empirical therapy for invasive candidiasis in adult pulmonary and critical care patients. An of\ufb01cial American Thoracic Society Clinical Practice Guideline","volume":"211","author":"Epelbaum","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02740_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01982-23","article-title":"Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis","volume":"15","author":"Gon\u00e7alves","year":"2024","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02740_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13054-026-05975-1","article-title":"Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature review","volume":"30","author":"Sedik","year":"2026","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.idcr.2026.e02740_bib12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02740_bib13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02740_bib14","first-page":"2532","article-title":"The application of next-generation sequencing in diagnosing invasive pulmonary aspergillosis: three case reports","volume":"11","author":"He","year":"2019","journal-title":"Am J Transl Res"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02740_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae252","article-title":"Diagnostic value of microbial cell-free DNA sequencing for suspected invasive fungal infections: a retrospective multicenter cohort study","volume":"11","author":"Huygens","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02740_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41525-025-00482-8","article-title":"NGS-based Aspergillus detection in plasma and lung lavage of children with invasive pulmonary aspergillosis","volume":"10","author":"Wesdorp","year":"2025","journal-title":"npj Genom Med"},{"key":"10.1016\/j.idcr.2026.e02740_bib17","article-title":"Early antifungal prophylaxis fails to prevent influenza-associated pulmonary aspergillosis in the ICU: a target trial emulation","author":"Li","year":"2026","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.idcr.2026.e02740_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100848","article-title":"A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: findings from the PRISM study","volume":"16","author":"Shim","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.idcr.2026.e02740_bib19","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2026. Available from: https:\/\/goldcopd.org\/wp-content\/uploads\/2026\/01\/GOLD-REPORT-2026-v1.3-8Dec2025_WMV2.pdf."},{"issue":"8","key":"10.1016\/j.idcr.2026.e02740_bib20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/myc.13293","article-title":"The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: systematic review and meta-analysis","volume":"64","author":"Zhang","year":"2021","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02740_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s13054-025-05697-w","article-title":"Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review","volume":"29","author":"Coste","year":"2025","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02740_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cpt.583","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and voriconazole therapy","volume":"102","author":"Moriyama","year":"2017","journal-title":"Clin Pharmacol Ther"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:13:08Z","timestamp":1790723588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"alternative-id":["S2214250926002532"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02740","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of severe influenza-associated pulmonary aspergillosis with invasive tracheobronchitis and bronchial asthma using combination antifungals and omalizumab: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02740"}}